BPTS — Biophytis SA Income Statement
0.000.00%
Last trade - 00:00
- $1.57m
- $6.11m
2018 December 31st | 2019 December 31st | R2020 December 31st | R2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue | |||||
Gross Profit | 0 | 0 | — | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 13.9 | 15.7 | 13.9 | 26.8 | 23.3 |
Operating Profit | -13.9 | -15.7 | -13.9 | -26.8 | -23.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -14.1 | -17.8 | -25.5 | -31.2 | -24.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -14 | -17.8 | -25.5 | -31.2 | -24.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -14 | -17.8 | -25.5 | -31.2 | -24.2 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -14 | -17.8 | -25.5 | -31.2 | -24.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.52 | -1.05 | -0.425 | -0.263 | -0.139 |
Dividends per Share |